Recombinant shingles vaccine linked to lower dementia risk, especially in women

[Ketua Dobbs]

Recombinant shingles vaccine linked to lower dementia risk, especially in women

Study published in Nature Medicine found that the recombinant shingles vaccine is linked to a reduced risk of dementia. This protective effect was particularly notable in females, suggesting a potential advantage of the recombinant vaccine over the live vaccine.
Source: Recombinant shingles vaccine linked to lower dementia risk, especially in women